National Health Investors (NYSE:NHI) Stock Rating Upgraded by Zacks Research

Key Points

• Zacks Research upgraded National Health Investors from “strong sell” to “hold.” Despite this, the broader analyst consensus remains “Moderate Buy,” with five Buy ratings and four Holds and an average price target of $82.25.
• NHI shares opened at $65.84, near their 52-week low of $65.51 and below the 50-day and 200-day moving averages. The stock has a market capitalization of approximately $3.23 billion.
• The healthcare REIT reported quarterly EPS of $1.19 on $121.32 million in revenue, up 1.6% year over year, and maintains fiscal-year EPS guidance of $4.74–$4.79. Institutional investors own 62.51% of the company.

National Health Investors (NYSE:NHI - Get Free Report) was upgraded by investment analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a report issued on Tuesday, Zacks reports.

A number of other equities research analysts have also weighed in on NHI. National Bank Financial set a $79.00 target price on shares of National Health Investors in a research note on Wednesday, September 9th. Huntington started coverage on National Health Investors in a research note on Thursday, September 10th. They set an "outperform" rating and a $79.00 price objective for the company. Truist Financial dropped their target price on National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a report on Wednesday, September 2nd. BMO Capital Markets reissued an "outperform" rating on shares of National Health Investors in a research note on Wednesday, September 23rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a report on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, National Health Investors has a consensus rating of "Moderate Buy" and a consensus price target of $82.25.

National Health Investors Stock Down 1.2%

Shares of NYSE:NHI opened at $65.84 on Tuesday. National Health Investors has a 1 year low of $65.51 and a 1 year high of $91.38. The company has a market cap of $3.23 billion, a PE ratio of 19.03, a P/E/G ratio of 3.56 and a beta of 0.52. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The stock's 50-day moving average is $72.18 and its 200 day moving average is $75.79.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The business had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company's quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Sell-side analysts anticipate that National Health Investors will post 4.76 EPS for the current year.

Institutional Trading of National Health Investors

A number of large investors have recently made changes to their positions in the stock. Deutsche Bank AG bought a new position in National Health Investors during the second quarter valued at approximately $9,252,000. Forty three Eighteen Advisors LLC bought a new stake in National Health Investors in the 1st quarter worth approximately $2,005,000. Bank of America Corp DE purchased a new stake in National Health Investors during the 2nd quarter valued at $77,738,000. Public Employees Retirement System of Ohio purchased a new stake in National Health Investors during the 2nd quarter valued at $4,243,000. Finally, Principal Financial Group Inc. lifted its holdings in shares of National Health Investors by 2.0% during the 1st quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust's stock valued at $137,537,000 after buying an additional 32,902 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc NYSE: NHI is a self-managed real estate investment trust that owns and finances healthcare-related real estate. The company primarily invests in properties used by seniors and patients, including senior housing communities, skilled nursing facilities, medical office buildings and other healthcare facilities.

NHI generally leases its properties to healthcare operators under long-term agreements and may provide mortgage or other financing to support the development and operation of healthcare real estate.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.